GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mauna Kea Technologies SA (OTCPK:MKEAF) » Definitions » Gross Margin %

Mauna Kea Technologies (Mauna Kea Technologies) Gross Margin % : 88.07% (As of Jun. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Mauna Kea Technologies Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Mauna Kea Technologies's Gross Profit for the six months ended in Jun. 2023 was $6.50 Mil. Mauna Kea Technologies's Revenue for the six months ended in Jun. 2023 was $7.38 Mil. Therefore, Mauna Kea Technologies's Gross Margin % for the quarter that ended in Jun. 2023 was 88.07%.


The historical rank and industry rank for Mauna Kea Technologies's Gross Margin % or its related term are showing as below:

MKEAF' s Gross Margin % Range Over the Past 10 Years
Min: 65.6   Med: 68.32   Max: 82.52
Current: 82.52


During the past 13 years, the highest Gross Margin % of Mauna Kea Technologies was 82.52%. The lowest was 65.60%. And the median was 68.32%.

MKEAF's Gross Margin % is ranked better than
91.95% of 795 companies
in the Medical Devices & Instruments industry
Industry Median: 53.37 vs MKEAF: 82.52

Mauna Kea Technologies had a gross margin of 88.07% for the quarter that ended in Jun. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Mauna Kea Technologies was 1.90% per year.


Mauna Kea Technologies Gross Margin % Historical Data

The historical data trend for Mauna Kea Technologies's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mauna Kea Technologies Gross Margin % Chart

Mauna Kea Technologies Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.55 65.60 67.09 74.16 73.19

Mauna Kea Technologies Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.70 76.80 73.11 73.26 88.07

Competitive Comparison of Mauna Kea Technologies's Gross Margin %

For the Medical Devices subindustry, Mauna Kea Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mauna Kea Technologies's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mauna Kea Technologies's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Mauna Kea Technologies's Gross Margin % falls into.



Mauna Kea Technologies Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Mauna Kea Technologies's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=5.8 / 7.923
=(Revenue - Cost of Goods Sold) / Revenue
=(7.923 - 2.124) / 7.923
=73.19 %

Mauna Kea Technologies's Gross Margin for the quarter that ended in Jun. 2023 is calculated as


Gross Margin % (Q: Jun. 2023 )=Gross Profit (Q: Jun. 2023 ) / Revenue (Q: Jun. 2023 )
=6.5 / 7.384
=(Revenue - Cost of Goods Sold) / Revenue
=(7.384 - 0.881) / 7.384
=88.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Mauna Kea Technologies  (OTCPK:MKEAF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Mauna Kea Technologies had a gross margin of 88.07% for the quarter that ended in Jun. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Mauna Kea Technologies Gross Margin % Related Terms

Thank you for viewing the detailed overview of Mauna Kea Technologies's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mauna Kea Technologies (Mauna Kea Technologies) Business Description

Traded in Other Exchanges
Address
9, rue d'Enghien, Paris, FRA, 75010
Mauna Kea Technologies SA is a medical device corporation. It is engaged in designing, developing, and marketing an imaging platform used to view tissues at a cellular level, in real-time, during standard procedures. The firm operates in the business segment of Endomicroscopy. The group's technological platform is Cellvizio which helps physicians to detect early-stage pathologies more accurately and make therapeutic decisions. It generates revenue from the sales of Cellvizio products and accessories used for medical diagnostics, research, and related services. The company sells its products in France and internationally, of which the majority of the revenue is derived from America.

Mauna Kea Technologies (Mauna Kea Technologies) Headlines